Novoic
About Novoic
Novoic is an AI-driven company specializing in early detection of Alzheimer's disease using speech-based cognitive testing. Their technology offers earlier Alzheimer's detection in as little as 10 minutes by analyzing subtle cognitive impairments and neuropathology through speech.
Technology and Impact
Novoic's software delivers a fully automated, scalable experience accessible via any smart device with a browser. It is designed for high usability, especially for elderly and cognitively impaired populations, and focuses on maximizing data integrity through advanced engineering and automated speech recognition.
The company supports early Alzheimer's detection across 50+ medical institutions and collaborates with initiatives such as the Alzheimer’s Disease Neuroimaging Initiative. Clinical trials validate their AI models for improved prediction, robustness, and fairness.
The Novoic Dashboard enables large-scale digital screening and patient monitoring with AI-assisted triage, user-friendly interfaces, and comprehensive analytics, facilitating multi-site clinical trials efficiently.